Research Article

Serum Vitamin D Among Patients withType 2 Diabetes Mellitus

Volume: 43 Number: 3 September 30, 2022
EN

Serum Vitamin D Among Patients withType 2 Diabetes Mellitus

Abstract

Vitamin D supplements are a beneficial health issue to benefit from insulin therapy. In those with T2DM, serum vit-D was checked and resuscitated. Serum vit-D was evaluated with its rich content. Serum vit D levels were statistically significantly lower in T2DM patients than in the control group. It was found to be significant in terms of the relationship between fasting blood sugar and vit-D and HbA1C. Vit-D in sugar will be used as a benefit from vit-D in patients with blood T2DM patients. The mean±SD vit-D level was 19.22±9.23 for the whole population with a fasting blood glucose level of 110 mg/dl or less, and 12.21±6.15 for people with a fasting blood glucose level above 130 mg/dl, and p<0.001. The relationship between vit-D level and fasting blood sugar is statistically significant with negative pearson correlation coefficient. Vit-D mean±SD 20.46±8.56 for the entire population with an HbA1C level equal to or lower than 6.5%, and 12.84±6% for individuals with a fasting blood glucose level above 6.5%, is 26 and p<0.001. The strong relationship between vit-D and fasting blood glucose and HbA1C is due to the fact that vit-D tends to specifically stimulate insulin production in β-pancreatic cells via the nuclear vit-D receptor (VDR) and that vit-D minimizes inflammation. Vit-D supplements are a beneficial health challenge to benefit from insulin therapy. Serum vit-D was checked in patients with T2DM. The serum has been evaluated with its rich content of vit-D. Serum vit-D levels were statistically significantly lower in T2DM patients compared to the control group. It was found to be significant in terms of the relationship between fasting blood sugar and vit-D and HbA1C. Vit-D in sugar will be used as a benefit from vit-D in blood T2DM patients.
Keywords: Vitamin D, Serum, Type 2 Diabetes Mellitus, Human.

Keywords

References

  1. [1] Adela R., Borkar R.M., Bhandi M.M., Vishwakarma Reddy P.N.C., Srinivas R., Banerjee S., Lower Vitamin D Metabolites Levels were Associated with Increased Coronary Artery Diseases in Type 2 Diabetes Patients in India, Sci. Rep., 6(12) (2016) 1–13.
  2. [2] Yassin M.M., Masoud A.E.R.D., Serum Vitamin D Status in Type 2 Diabetic Patients from Gaza Strip, Diabetes Metab., 13(3) (2019) 1865–1870.
  3. [3] Risérus U., Willett W.C., Hu F.B., Dietary Fats and Prevention of T2DM, Prog. Lipid Res., 48(1) (2009) 44–51.
  4. [4] Holick M.F., Schnoes H.K., Deluca H.F., Suda T., Cousins R.J., Isolation and Identification of 1,25-Dihydroxycholecalciferol a Metabolite of Vitamin D Active in Intestine, Biochemistry, 10(14) (1971) 2799–2804.
  5. [5] Turner B., Williams S., Taichman D., Vijan S., The Clinic Type 2 Diabetes Screening and Prevention Diagnosis and Evaluation Practice Improvement CME Questions, 2010.
  6. [6] Giovannuc E., Harlan D.M., Archer M.C., Bergenstal R.M., Gapstur S.M., Habel L.A., Pollak M., Regensteiner J.G., Yee D., Diabetes and Cancer: A Consensus Rreport, Diabetes Care, 33(7) (2010)1674–1685.
  7. [7] Saad F., Gooren L., The Role of Testosterone in The Metabolic Syndrome: A Review, J.Steroid Biochem. Mol. Biol., 114 (2) (2009) 40–43.
  8. [8] D. O. F. Diabetes, Diagnosis and Classification of Diabetes Mellitus, Diabetes Care, 35(1) (2012).

Details

Primary Language

English

Subjects

-

Journal Section

Research Article

Publication Date

September 30, 2022

Submission Date

March 25, 2022

Acceptance Date

July 2, 2022

Published in Issue

Year 2022 Volume: 43 Number: 3

APA
Ahmed, S., & Sarı, A. (2022). Serum Vitamin D Among Patients withType 2 Diabetes Mellitus. Cumhuriyet Science Journal, 43(3), 423-431. https://doi.org/10.17776/csj.1048422

As of 2026, Cumhuriyet Science Journal will be published in six issues per year, released in February, April, June, August, October, and December